Benralizumab can be used for the treatment of acute eosinophilic exacerbations of asthma and chronic obstructive pulmonary ...

Rx, a leading digital medicine and biomarker company driving healthcare through pulmonary innovation, today announced that it will launch purpleDx, a cardiopulmonary assessment app built to medical ...

US FDA accepts GSK’s submission for the use of Nucala to treat patients with chronic obstructive pulmonary disease: London, UK Wednesday, December 11, 2024, 10:00 Hrs [IST] GSK ...

Every 30 seconds, someone in the world will experience a flare-up of their asthma or chronic obstructive pulmonary disease (COPD) symptoms. For decades, the standard treatment for these ...

Residents of Timișoara, in western Romania, can undergo free spirometry tests in a special tram as part of the ...

According to the World Health Organization (WHO), chronic obstructive pulmonary disease (COPD) is the third leading cause of ...

While smoking remains the leading risk factor for COPD, non-smokers should be aware of other environmental and occupational ...

Obesity has this year overtaken smoking as Australia's leading risk factor contributing to disease, according to a national ...

November is National Chronic Obstructive Pulmonary Disease Awareness Month. It’s time to raise awareness about lung disease within our communities. By understanding the causes, reducing our risk ...

CNW/ - Chronic diseases don't discriminate when it comes to age. A new report from Sun Life points to more and more young ...

A systematic review reveals chronic pulmonary aspergillosis mortality is driven by age and underlying conditions, ...

Chronic pulmonary aspergillosis (CPA) is a collection of progressive diseases of the lung caused by infection with members of the Aspergillus genus. The five subtypes of CPA are aspergilloma, ...